R Raedsch
Overview
Explore the profile of R Raedsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raedsch R, Hanisch J, Bock P, Sibaev A, Vinson B, Gundermann K
Z Gastroenterol
. 2007 Oct;
45(10):1041-8.
PMID: 17924300
Aim: The objective of this study was to assess the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia. Methods: A retrolective, epidemiological cohort study with...
2.
von Kiedrowski R, Huijghebaert S, Raedsch R
Dig Dis Sci
. 2001 May;
46(5):939-44.
PMID: 11341662
Regulation of gallbladder motility is complex. Mechanisms via which cisapride may interact with gallbladder function are being reviewed. These are multiple and include direct effects on gallbladder and the sphincter...
3.
Walter-Sack I, de Vries J, Ittensohn A, Raedsch R
Eur J Med Res
. 1998 Mar;
3(1-2):45-9.
PMID: 9512967
Hepatic metabolism of the uricosuric drug benzbromarone results in the formation of two hydroxilated main metabolites M1 (1'-hydroxybenzbromarone) and M2 (6-hydroxybenzbromarone). As urinary excretion of benzbromarone and its metabolites is...
4.
Caesar I, Gross V, Roth M, Andus T, Schmidt C, Raedsch R, et al.
Hepatogastroenterology
. 1997 Mar;
44(14):445-51.
PMID: 9164517
Background/aims: Budesonide is a glucocorticoid with a high topical anti-inflammatory but low systemic activity due to its rapid hepatic inactivation. The aim of this open, multicenter study was to investigate...
5.
Rudi J, Toppe H, Marx N, Zuna I, Theilmann L, Stremmel W, et al.
Am J Gastroenterol
. 1997 Feb;
92(2):258-62.
PMID: 9040202
Objectives: The purpose of this study was to determine whether different staff groups in an acute care hospital are at increased risk of acquiring Helicobacter pylori and hepatitis A virus...
6.
Weisgerber U, Boeing H, Owen R, Waldherr R, Raedsch R, Wahrendorf J
Gut
. 1996 Mar;
38(3):396-402.
PMID: 8675093
A longterm, double blind intervention trial was undertaken in patients with sporadic adenoma treated by polypectomy to investigate the putative role of calcium as a protective factor in colon carcinogenesis....
7.
Rudi J, Waldherr R, Raedsch R, Stremmel W
Eur J Gastroenterol Hepatol
. 1995 Nov;
7(11):1081-6.
PMID: 8680908
Background: Recent studies have shown that serum levels of hepatocyte growth factor, a potent mitogen for hepatocytes, are increased in patients with fulminant liver failure and with advanced stages of...
8.
Walter-Sack I, de Vries J, von Bubnoff A, Pfleilschifter V, Raedsch R
Eur J Med Res
. 1995 Oct;
1(1):16-20.
PMID: 9392688
The disposition of benzbromarone and its uric acid lowering effect were investigated in 8 patients with compensated liver cirrhosis in order to obtain evidence whether dose requirements differ from subjects...
9.
Rudi J, Muller M, von Herbay A, Zuna I, Raedsch R, Stremmel W, et al.
Scand J Gastroenterol
. 1995 Oct;
30(10):958-63.
PMID: 8545615
Background: Previous studies have suggested that infection with Helicobacter pylori is associated with an increased risk of gastric adenocarcinoma. Methods: We examined the sera of 111 Caucasian patients with histologically...
10.
Hildebrandt R, Gundert-Remy U, Raedsch R, Sieg A, Stiehl A
Int J Clin Pharmacol Ther
. 1995 Jul;
33(7):384-7.
PMID: 7582392
In three patients with liver disease (2 patients with alcoholic liver cirrhosis and 1 patient with chronic cholangitis) total, renal, biliary and metabolic clearance of the acylureidopenicillin mezlocillin was examined...